Page last updated: 2024-11-12

kalkitoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kalkitoxin: from marine cyanobacterium, Lyngbya majuscula [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11176051
CHEBI ID186963
MeSH IDM0336720

Synonyms (13)

Synonym
(2r)-n-[(3s,5s,6r)-7-[(4r)-4-ethenyl-4,5-dihydro-1,3-thiazol-2-yl]-3,5,6-trimethylheptyl]-n,2-dimethylbutanamide
kalkitoxin
247184-89-0
CHEBI:186963
kalkitoxin, (+)-
kalkitoxin [mi]
butanamide, n-((3s,5s,6r)-7-((4r)-4-ethenyl-4,5-dihydro-2-thiazolyl)-3,5,6-trimethylheptyl)-n,2-dimethyl-, (2r)-
79jc6zx2r6 ,
unii-79jc6zx2r6
(2r)-n-((3s,5s,6r)-7-((4r)-4-ethenyl-4,5-dihydro-2-thiazolyl)-3,5,6-trimethylheptyl)-n,2-dimethylbutanamide
CCG-257470
Q27266756
DTXSID80897233

Research Excerpts

Overview

Kalkitoxin (KT) is an active lipopeptide isolated from the cyanobacterium.

ExcerptReferenceRelevance
"Kalkitoxin (KT) is an active lipopeptide isolated from the cyanobacterium "( Kalkitoxin attenuates calcification of vascular smooth muscle cells via RUNX-2 signaling pathways.
Kim, SW; Shrestha, SK; Soh, Y, 2023
)
3.8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
fatty amideA monocarboxylic acid amide derived from a fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.93 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]